Additionally, the application of a GPR103 antagonist during an oral glucose test in B6 mice on a standard chow diet resulted in severe hyperglycemia with significant insulin sensitivity reduction (Prévost et al., 2019a). The gene discussed is INS; the disease is Hyperglycemia.